EPT - Condensed Consolidated Statements of Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Distributions in Excess of Accumulated Earnings	Accumulated Other Comprehensive Income, net	Noncontrolling Interest
Balance at period beginning (in shares) at Dec. 31, 2024		64,280,000
Balance at period beginning at Dec. 31, 2024	$ 5,720,390	$ 6	$ 6,668,047	$ (1,155,662)	$ 24,655	$ 183,344
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	617,028			589,093		27,935
Reversal of unrealized gains upon the sale of marketable debt securities, net	(17)				(16)	(1)
Change in fair value of derivatives and amortization of swap settlements	(17,571)				(16,977)	(594)
Change in fair value of marketable debt securities, net	201				194	7
Issuance of common stock under:
Stock option and restricted stock plans, net (in shares)		49,000
Stock option and restricted stock plans, net	8,370		8,370
Sale of common stock, net	(280)		(280)
Equity-based compensation costs	7,021		6,783			238
Changes in the redemption value of redeemable noncontrolling interest	1,103		1,314			(211)
Distributions to noncontrolling interest	(24,677)					(24,677)
Redemptions of noncontrolling interest (in shares)		75,000
Redemptions of noncontrolling interest	(13,475)		2,355			(15,830)
Common stock dividends	(496,566)			(496,566)
Balance at period end (in shares) at Sep. 30, 2025		64,404,000
Balance at period end at Sep. 30, 2025	5,801,527	$ 6	6,686,589	(1,063,135)	7,856	170,211
Balance at period beginning (in shares) at Jun. 30, 2025		64,404,000
Balance at period beginning at Jun. 30, 2025	5,805,914	$ 6	6,685,714	(1,062,146)	11,675	170,665
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	172,724			164,621		8,103
Reversal of unrealized gains upon the sale of marketable debt securities, net	(17)				(16)	(1)
Change in fair value of derivatives and amortization of swap settlements	(4,050)				(3,913)	(137)
Change in fair value of marketable debt securities, net	114				110	4
Issuance of common stock under:
Stock option and restricted stock plans, net	(41)		(41)
Sale of common stock, net	(179)		(179)
Equity-based compensation costs	2,607		2,519			88
Changes in the redemption value of redeemable noncontrolling interest	3,176		3,016			160
Distributions to noncontrolling interest	(8,192)					(8,192)
Redemptions of noncontrolling interest	(4,919)		(4,440)			(479)
Common stock dividends	(165,610)			(165,610)
Balance at period end (in shares) at Sep. 30, 2025		64,404,000
Balance at period end at Sep. 30, 2025	5,801,527	$ 6	6,686,589	(1,063,135)	7,856	170,211
Balance at period beginning (in shares) at Dec. 31, 2025		64,442,000
Balance at period beginning at Dec. 31, 2025	5,708,632	$ 6	6,683,514	(1,148,195)	6,047	167,260
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	282,872			266,717		16,155
Reversal of unrealized gains upon the sale of marketable debt securities, net	(43)				(43)
Change in fair value of derivatives and amortization of swap settlements	23,569				22,791	778
Change in fair value of marketable debt securities, net	(1,418)				(1,369)	(49)
Issuance of common stock under:
Stock option and restricted stock plans, net (in shares)		30,000
Stock option and restricted stock plans, net	4,427		4,427
Sale of common stock, net (in shares)		53,000
Sale of common stock, net	16,215		16,215
Equity-based compensation costs	10,262		9,924			338
Retirement of common stock, net (in shares)		(254,000)
Retirement of common stock, net	(61,915)		(61,915)
Changes in the redemption value and redemptions of redeemable noncontrolling interest (in shares)		67,000
Changes in the redemption value of redeemable noncontrolling interest	2,194		1,832			362
Changes in noncontrolling interest from acquisition	0		(250)			250
Distributions to noncontrolling interest	(24,041)					(24,041)
Redemptions of noncontrolling interest	(1,592)		(1,465)			(127)
Common stock dividends	(499,708)			(499,708)
Balance at period end (in shares) at Sep. 30, 2026		64,338,000
Balance at period end at Sep. 30, 2026	5,459,454	$ 6	6,652,282	(1,381,186)	27,426	160,926
Balance at period beginning (in shares) at Jun. 30, 2026		64,268,000
Balance at period beginning at Jun. 30, 2026	5,485,516	$ 6	6,626,545	(1,312,602)	9,124	162,443
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	103,735			98,069		5,666
Reversal of unrealized gains upon the sale of marketable debt securities, net	(17)				(17)
Change in fair value of derivatives and amortization of swap settlements	20,068				19,406	662
Change in fair value of marketable debt securities, net	(1,125)				(1,087)	(38)
Issuance of common stock under:
Stock option and restricted stock plans, net (in shares)		17,000
Stock option and restricted stock plans, net	4,334		4,334
Sale of common stock, net (in shares)		53,000
Sale of common stock, net	16,274		16,274
Equity-based compensation costs	4,072		3,938			134
Changes in the redemption value of redeemable noncontrolling interest	1,304		1,220			84
Distributions to noncontrolling interest	(8,024)					(8,024)
Redemptions of noncontrolling interest	(30)		(29)			(1)
Common stock dividends	(166,653)			(166,653)
Balance at period end (in shares) at Sep. 30, 2026		64,338,000
Balance at period end at Sep. 30, 2026	$ 5,459,454	$ 6	$ 6,652,282	$ (1,381,186)	$ 27,426	$ 160,926